ClinicalTrials.gov
public full text
Public Domain
PET Tau - Neurodegenerative Disease Imaging
The purpose of this study is to measure the amount of a protein in the brain known as tau using an imaging procedure called Positron Emission Tomography (PET/CT). Tau has been shown to build up in the brains of patients with injury to brain cells. This study looks at neurodegenerative diseases such as frontotemporal degeneration (FTD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis#1138165
- Application of Multi-probe PET/MR Imaging in the Diagnosis and Evaluation of Alzheimer's Disease#837321
- [(18)F]Fluorodeoxyglucose positron emission tomography ([(18)F]FDG PET) Characterizes Neurodegeneration Levels Across the α-Synucleinopathy Continuum.#396054
- 18F-deoxyglucose (FDG) PET-CMD#1111943
- Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognition.#670978
Record · ID 831750
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive